-

-
3,3’,5,5’-Tetramethylbenzidine ; CAS# / EC#:54827-17-7OPD TMB [查看]
-
http://www.cxbio.com/Products/3355SJJLBA_453.html
-

-
3,3’,5,5’-Tetramethylbenzidine dihydrochloride; CAS# / EC#:64285-73-0 OPD TMB-2HCL 水溶性较TMB好[查看]
-
http://www.cxbio.com/Products/3355SJJLBAEYSY.html
-

-
N-(3-Sulfopropyl)-3,3’,5,5’-tetramethylbenzidine sodium salt ; CAS# / EC#:102062-36-2 TMBTMB-PS [查看]
-
http://www.cxbio.com/Products/N3HBJ3303955SJJLBANY.html
-

-
2,3,5-Triphenyltetrazolium chloride; CAS# / EC#:298-96-4TMB-2HCL TTC [查看]
-
http://www.cxbio.com/Products/HSZ235SBJLHSDZ.html
-
![3,3'-[1-(苯氨酰基)-3,4-四氮唑]-二(4-甲氧基-6-硝基)苯磺酸钠 3,3'-[1-(苯氨酰基)-3,4-四氮唑]-二(4-甲氧基-6-硝基)苯磺酸钠](http://www.cxbio.com/UploadFiles/Others/product_no_pic.gif)
-
Sodium3,3'-[1-(phenylamino)carbonyl]-3,4-tetrazolium-bis(4-methoxy-6-nitro)benzenesulfonic acid; CAS# / EC#:111072-31-2TMB-PS XTT 体外细胞增殖、药敏检测等细胞活性检测[查看]
-
http://www.cxbio.com/Products/330391BAXJ34SDZE4JYJ.html
-

-
TMB 3,3',5,5'-Tetramethylbenzidine CAS:54827-17-7 级别/纯度 ;[查看]
-
http://www.cxbio.com/Products/3355SJJLBA_2.html
-

-
TMB-PS CAS:102062-36-2 级别/纯度>99.0%;[查看]
-
http://www.cxbio.com/Products/N3HBJ3355SJJLBANY.html
-

-
TMB .2HCl 3,3',5,5'-Tetramethylbenzidine dihydrochloride CAS:64285-73-0 级别/纯度>99.0%, Advanced;[查看]
-
http://www.cxbio.com/Products/3355SJJLBAYSY_2.html
-

-
染料EB(溴化乙锭)的新型替代品,无毒无致使癌副作用 CAS: 级别/纯度>99.0%;[查看]
-
http://www.cxbio.com/Products/GeneFindrTM.html
-

-
Litmus CAS:1393-92-6 级别/纯度 ;[查看]
-
http://www.cxbio.com/Products/SR.html
-

-
TMB;EC #/ CAS: 54827-17-7;[查看]
-
http://www.cxbio.com/Products/3355Tetramethylbenzi.html
-

-
TMB;EC #/ CAS: 54827-17-7;[查看]
-
http://www.cxbio.com/Products/3355Tetramethylbenzi_1028.html
-

-
MTMC Standard CAS#:1129-41-5 品牌:wako;订货号:131-06821 类别:wako农药标准品[查看]
-
http://www.cxbio.com/Products/SMWBZP.html
-

-
Varian 920-LC 高效液相色谱仪以及Varian PursuitTM PAH 色谱柱,应用美国EPA颁布的8310 方法,在15 分钟内快速地分离分析18 种PAHs 混合物。不仅大大节约了试剂和时间的消耗,同时提高了分析通量,相对常规法,一次分离分析更多PAHs 化合物。上海西宝生物科技有限公司提供多种多环芳烃标准品和多环芳烃混合标准溶液[查看]
-
http://www.cxbio.com/Projects/dhftpahsjcjjfa.html
-

-
在肿瘤治疗领域迎来重要突破!最新发表在权威期刊的研究揭示了靶向滋养层细胞表面抗原2(TROP-2)的抗体偶联药物(ADC)sacituzumab tirumotecan(sac-TMT/MK-2870/SKB264)与程序性死亡配体1(PD-L1)抑制剂tagitanlimab(KL-A167)的强强联合。这项代号为OptiTROP-Lung01的多中心II期临床试验,专门针对无可用药基因突变的晚期非小细胞肺癌患者设计了两套创新给药方案。[查看]
-
http://www.cxbio.com/Article/20250820_industrialnews_1.html